New Key Statistics Module, Z-Score and F-Score
OTCPK:TRXPF Key Ratios
| Market Cap $ M | 670.71 |
| Enterprise Value $ M | 391.49 |
| P/E(ttm) | 19.89 |
| PE Ratio without NRI | 19.94 |
| Forward PE Ratio | -- |
| Price/Book | 0.88 |
| Price/Sales | 1.87 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 386.00 |
| EPS (TTM) $ | 1.30 |
| Beneish M-Score | -1.94 |
| 10-y EBITDA Growth Rate % | 2.60 |
| 5-y EBITDA Growth Rate % | -9.40 |
| y-y EBITDA Growth Rate % | 75.80 |
| EV-to-EBIT | 8.57 |
| EV-to-EBITDA | 8.57 |
| PEG | -- |
| Shares Outstanding M | 28.11 |
| Net Margin (%) | 9.39 |
| Operating Margin % | 12.19 |
| Pre-tax Margin (%) | 12.72 |
| Quick Ratio | 5.58 |
| Current Ratio | 6.50 |
| ROA % (ttm) | 4.00 |
| ROE % (ttm) | 4.45 |
| ROIC % (ttm) | 6.41 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.93 |
TRXPF Number of Guru Trades
TRXPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TRXPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TRXPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Torii Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:TRXPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers